Psychotherapy News and Research

RSS

Psychotherapy is “talk” therapy. It involves talking with a mental health professional to treat a mental illness. Psychotherapy can occur one-on-one or in a group. Research shows that support from family and friends can be an important part of therapy.

Virtual reality app trial offers new hope for people suffering from phobias

Results from a University of Otago, Christchurch trial suggest fresh hope for the estimated one-in-twelve people worldwide suffering from a fear of flying, needles, heights, spiders and dogs.

14 Jul 2022

Digital mental health companies draw scrutiny and growing concerns

When Pat Paulson's son told her he was feeling anxious and depressed at college, Paulson went through her Blue Cross Blue Shield provider directory and started calling mental health therapists.

8 Jul 2022

Innovative treatment reduces post-traumatic headache related disability, study finds

The first therapy to be developed specifically for post-traumatic headache significantly reduced related disability in veterans following a traumatic brain injury (TBI).

27 Jun 2022

Evidence-based study shows how hypnotherapy provides positive outcomes for IBS patients

It is common that Hong Kong people might have experiences of disordered defecation with unknown reason, such as diarrhea and constipation. It is also easy to observe that abdominal discomforts often come along with stress. Emotion disturbance and stress might affect our intestinal functions.

14 Jun 2022

Combining psychotherapy with antidepressants does not improve outcomes in severely depressed patients

Antidepressants are the first-choice treatment for severe depression. Antidepressant use is often supplemented by psychotherapy.

6 Jun 2022

Black youth in racist communities less likely to benefit from psychotherapy

A study in the Journal of the American Academy of Child and Adolescent Psychiatry (JAACAP), published by Elsevier, reports that Black youth living in communities with high (vs. low) anti-Black racism are less likely to benefit from psychotherapy ("talk therapy;" such as cognitive behavioral therapy).

2 Jun 2022

Neuroimaging advances show promise in helping transcranial electrical stimulation to effectively treat visual hallucinations

A literature review in Harvard Review of Psychiatry indicates that, while transcranial electrical stimulation (tES) has rarely been used in treating visual hallucinations (VH) among patients with psychiatric disorders, recent advances in neuroimaging technology show promise in helping tES to more effectively treat VH in psychiatric disorders where VH are a core symptom.

13 May 2022

The effect of antidepressants on patient-reported health-related quality of life

A new study published in PLoS ONE aimed to investigate the effect of using antidepressant medications on the HRQoL of patients with depression.

27 Apr 2022

Study highlights the 'staggering' economic burden of PTSD

A new study finds that the national economic burden of PTSD goes beyond direct health care expenses and exceeds the costs of other common mental health conditions, such as anxiety and depression.

25 Apr 2022

Study shows inequality in access to and quality of psychiatric care for children with migrant backgrounds

Children with migration backgrounds in Sweden are less likely than other children to receive recommended treatment for psychiatric diagnoses such as ADHD and depression, a paper from Karolinska Institutet published in the journal Epidemiology and Psychiatric Sciences reports.

21 Apr 2022

Scientists receive $4.6 million for a program that matches mental health patients with psychotherapists

A University of Massachusetts Amherst psychologist has received a $4.6 million funding award from the Patient-Centered Outcomes Research Institute (PCORI) to implement a program that matches mental health patients with psychotherapists based on the therapist's previously established effectiveness strengths.

20 Apr 2022

Depressive disorders are associated with general increase in the deformability of immune cells

A recent study by the TU Dresden and the University of Zurich in cooperation with the Max Planck Institute for the Science of Light establishes for the first time a link between depressive disorders and mechanical characteristics of all major blood cell types.

8 Apr 2022

Large-scale study sheds more light on the genetic basis of schizophrenia

What is the role of genetics in schizophrenia? To address this question, an international group of researchers led by Charité – Universitätsmedizin Berlin and Cardiff University developed and conducted the largest-ever genetic study on schizophrenia.

7 Apr 2022

A psychedelic drug plus psychotherapy could help improve PTSD symptoms

Post-traumatic stress disorder (PTSD) affects millions of people each year, mostly survivors and witnesses of terrifying or shocking events, such as warfare, assaults or disasters. Because existing treatments don't work for everyone, new therapies are urgently needed.

22 Mar 2022

Researchers find ketamine to have significant anti-depressant and anti-suicidal effects

First manufactured more than 50 years ago, ketamine is a fast-acting dissociative anesthetic often used in veterinary and emergency medicine. Ketamine also has a history of being an illicit party drug.

18 Mar 2022

Behavioral psychedelics: Fostering changes in habits, behaviors to improve health and resilience

Despite their reputation as illicit drugs, psychedelics may find new, legitimate roles in treatment for anxiety, depression, stress disorders, addiction, and other mental and behavioral health problems.

16 Mar 2022

Stress appears to have a negative effect on the learning of movements in mice

Stress seems to have a negative effect on the learning of movements - at least in mice. This is the conclusion of a recent study at the University of Bonn.

8 Mar 2022

Study offers insight into molecular biology of the brain in bipolar disorder patients

In a comprehensive study involving one of the largest-ever samples of post-mortem brains, scientists at the Lieber Institute for Brain Development, in collaboration with researchers at the Johns Hopkins School of Medicine and Bloomberg School of Public Health, have pinpointed significant differences in gene expression in two specific regions of the brains of hundreds of patients who had bipolar disorder.

7 Mar 2022

New signature initiative on increasing alcohol taxes could benefit people’s health, reduce mortality

Across the Region, alcohol consumption leads to almost one million deaths each year from a wide range of causes, including cardiovascular diseases, cancers and other noncommunicable diseases (NCDs), as well as infectious diseases and injuries.

28 Feb 2022

Two doses of psilocybin may ease depression symptoms for up to 12 months

Previous studies by Johns Hopkins Medicine researchers showed that psychedelic treatment with psilocybin relieved major depressive disorder symptoms in adults for up to a month.

15 Feb 2022